Hält derzeit eine Position bei Fulcrum Therapeutics Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Director | Fulcrum Therapeutics Inc | None - |
Director | Epizyme Inc | 10. September 2015 - 1. Juni 2016 |
President, Chief Executive Officer, Director | Epizyme Inc | 3. Februar 2015 - 10. September 2015 |
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Director | Epizyme Inc | 1. Oktober 2014 - 3. Februar 2015 |
Chief Executive Officer, Director | Epizyme Inc | 1. Juli 2013 - 1. Oktober 2014 |
President, Chief Executive Officer, Director | Epizyme Inc | 1. März 2010 - 1. Juli 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-13 | 2023-01-13 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
6.766
-1.3%
15,00101.490 USD |
6.766 -1.3% | 15,00 | 101.490 USD | |
2022-06-08 | 2022-06-07 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
71.435
-12.4%
8,09577.895 USD |
71.435 -12.4% | 8,09 | 577.895 USD | |
2022-06-06 | 2022-06-06 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
24.382
-4.6%
8,10197.592 USD |
24.382 -4.6% | 8,10 | 197.592 USD | |
2022-06-06 | 2022-06-03 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
25.551
-4.8%
7,95203.056 USD |
25.551 -4.8% | 7,95 | 203.056 USD | |
2022-06-06 | 2022-06-02 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
16.689
-3.2%
7,92132.162 USD |
16.689 -3.2% | 7,92 | 132.162 USD | |
2022-04-11 | 2022-04-07 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
5.631
-1.1%
24,02135.228 USD |
5.631 -1.1% | 24,02 | 135.228 USD | |
2022-04-05 | 2022-04-05 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
52.552
-9.4%
24,261.274.775 USD |
52.552 -9.4% | 24,26 | 1.274.775 USD | |
2022-04-05 | 2022-04-04 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
7.235
-1.4%
24,02173.749 USD |
7.235 -1.4% | 24,02 | 173.749 USD | |
2022-04-05 | 2022-04-01 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
34.464
-6.4%
24,03828.160 USD |
34.464 -6.4% | 24,03 | 828.160 USD | |
2021-03-17 | 2021-03-16 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
789
-0.2%
12,439.806 USD |
789 -0.2% | 12,43 | 9.806 USD | |
2021-03-17 | 2021-03-15 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
9.211
-1.8%
12,13111.773 USD |
9.211 -1.8% | 12,13 | 111.773 USD | |
2021-02-18 | 2021-02-16 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
1.673
-0.3%
14,5624.367 USD |
1.673 -0.3% | 14,56 | 24.367 USD | |
2021-02-18 | 2021-02-16 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
6.542
-1.2%
14,1992.830 USD |
6.542 -1.2% | 14,19 | 92.830 USD | |
2021-01-22 | 2021-01-20 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
10.000
-1.9%
12,08120.826 USD |
10.000 -1.9% | 12,08 | 120.826 USD | |
2020-07-09 | 2020-07-08 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
2.500
-0.5%
20,0050.000 USD |
2.500 -0.5% | 20,00 | 50.000 USD | |
2020-06-26 | 2020-06-25 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
2.500
-0.5%
20,8051.992 USD |
2.500 -0.5% | 20,80 | 51.992 USD | |
2020-06-10 | 2020-06-09 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
156
-0.0%
20,003.120 USD |
156 -0.0% | 20,00 | 3.120 USD | |
2020-06-09 | 2020-06-05 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
3.433
-0.6%
20,1769.251 USD |
3.433 -0.6% | 20,17 | 69.251 USD | |
2020-06-05 | 2020-06-04 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
1.300
-0.2%
20,0426.058 USD |
1.300 -0.2% | 20,04 | 26.058 USD | |
2020-06-05 | 2020-06-03 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
1.500
-0.3%
20,1330.192 USD |
1.500 -0.3% | 20,13 | 30.192 USD | |
2020-06-03 | 2020-06-02 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
2.797
-0.5%
20,0055.940 USD |
2.797 -0.5% | 20,00 | 55.940 USD | |
2020-06-03 | 2020-06-01 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
5
-0.0%
20,00100 USD |
5 -0.0% | 20,00 | 100 USD | |
2020-06-01 | 2020-05-29 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
1.390
-0.3%
20,0827.911 USD |
1.390 -0.3% | 20,08 | 27.911 USD | |
2020-06-01 | 2020-05-28 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
1.919
-0.3%
20,0138.391 USD |
1.919 -0.3% | 20,01 | 38.391 USD | |
2020-05-28 | 2020-05-26 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
2.500
-0.5%
20,0050.000 USD |
2.500 -0.5% | 20,00 | 50.000 USD | |
2020-02-20 | 2020-02-19 |
Fulcrum Therapeutics Inc
(FULC)
|
GV Geplanter Verkauf |
2.500
-0.4%
20,0050.000 USD |
2.500 -0.4% | 20,00 | 50.000 USD |